BIOMAT Database Logo BIOMAT Database Logo

Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway. 2009

Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Department of Animal Sciences, Graduate School of Agriculture and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.

Growth hormone (GH) pretreatment of 3T3-L1 adipocytes resulted in a concentration- and time-dependent inhibition of insulin-stimulated glucose uptake. Surprisingly, this occurred without significant effect on insulin-stimulated glucose transporter (GLUT) 4 translocation or fusion with the plasma membrane. In parallel, the inhibitory actions of chronic GH pretreatment also impaired insulin-dependent activation of phosphatidylinositol (PI) 3-kinase bound to insulin receptor substrate (IRS)-2 but not to IRS-1. In addition, insulin-stimulated Akt phosphorylation was inhibited by GH pretreatment. In contrast, overexpression of IRS-2 or expression of a constitutively active Akt mutant prevented the GH-induced insulin resistance of glucose uptake. Moreover, small interfering RNA-mediated IRS-2 knockdown also inhibited insulin-stimulated Akt activation and glucose uptake without affecting GLUT4 translocation and plasma membrane fusion. Together, these data support a model in which chronic GH stimulation inhibits insulin-dependent activation of phosphatidylinositol 3-kinase through a specific interaction of phosphatidylinositol 3-kinase bound to IRS-2. This inhibition leads to suppression of Akt activation coupled to glucose transport activity but not translocation or plasma membrane fusion of GLUT4.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins
D051275 Glucose Transporter Type 4 A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake. GLUT-4 Protein,GLUT4 Protein,Insulin-Responsive Glucose Transporter,SLC2A4 Protein,Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein,GLUT 4 Protein,Glucose Transporter, Insulin-Responsive,Insulin Responsive Glucose Transporter
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway.
April 2007, The Journal of biological chemistry,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
NCS-1 inhibits insulin-stimulated GLUT4 translocation in 3T3L1 adipocytes through a phosphatidylinositol 4-kinase-dependent pathway.
July 2002, The Journal of biological chemistry,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes.
August 2000, The Journal of biological chemistry,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport.
September 1998, The Journal of biological chemistry,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway.
November 2003, The Journal of endocrinology,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway.
November 2006, Endocrinology,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
In vivo administration of glucosamine inhibited phosphatidylinositol 3-kinase activity without affecting tyrosine phosphorylation of the insulin receptor or insulin receptor substrate in rat adipocytes.
August 2002, The Kobe journal of medical sciences,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes.
December 2003, The Biochemical journal,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation.
October 2005, American journal of physiology. Endocrinology and metabolism,
Naoko Sasaki-Suzuki, and Kiyoshi Arai, and Tomomi Ogata, and Kouhei Kasahara, and Hideyuki Sakoda, and Kazuhiro Chida, and Tomoichiro Asano, and Jeffrey E Pessin, and Fumihiko Hakuno, and Shin-Ichiro Takahashi
Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway.
May 2008, American journal of physiology. Endocrinology and metabolism,
Copied contents to your clipboard!